Hematologic Disorders

Jan 19, 2021| Posted in: Cancers, Drug Development, Hematologic Disorders, Treatment

Janssen Initiates Rolling Submission to FDA for cilta-cel to Treat Relapsed/Refractory Multiple Myeloma

Mark Wildgust, PhD, Vice President, Oncology Global Media…
Jan 17, 2021| Posted in: Cancers, Hematologic Disorders, Treatment

Overview of ECHELON-1 Study for Hodgkin Lymphoma

Dr. Anna Sureda, Head of the Onco-Hematology Service…
Jan 14, 2021| Posted in: Cancers, Hematologic Disorders

Overview of Hodgkin Lymphoma

Dr. Anna Sureda, Head of the Onco-Hematology Service…
Jan 12, 2021| Posted in: Congenital And Genetic Conditions, Heart Diseases, Hematologic Disorders, Lysosomal Storage Disorders, Metabolic Disorders, Neurology/Nervous System Diseases, Ophthalmology/Eye Diseases, Skin Conditions, Treatment

Determining the Best Treatment Option for Fabry Disease

Robert Hopkin, MD, Associate Professor of Clinical Pediatrics…
Jan 8, 2021| Posted in: Congenital And Genetic Conditions, Heart Diseases, Hematologic Disorders, Kidney And Urinary Diseases, Lysosomal Storage Disorders, Metabolic Disorders, Neurology/Nervous System Diseases, Ophthalmology/Eye Diseases, Skin Conditions

Overview of Fabry Disease

Robert Hopkin, MD, Associate Professor of Clinical Pediatrics…
Jan 4, 2021| Posted in: Autoimmune / Autoinflammatory Disorders, Cancers, Congenital And Genetic Conditions, Drug Development, Endocrine Disorders, Gastrointestinal Diseases, Heart Diseases, Hematologic Disorders, Kidney And Urinary Diseases, Lung Diseases, Lysosomal Storage Disorders, Metabolic Disorders, Musculoskeletal Diseases, Neurology/Nervous System Diseases, News, Ophthalmology/Eye Diseases, Skin Conditions, Treatment

Orphan Drugs Currently Under Review by the FDA

Every potential Food and Drug Administration (FDA) approval…
Jan 1, 2021| Posted in: Cancers, Hematologic Disorders, Treatment

Brief Overview of CLL Treatment Landscape

Lori Leslie, MD, Assistant Professor at Hackensack Meridian…
Dec 31, 2020| Posted in: Cancers, Hematologic Disorders

Chronic Lymphocytic Leukemia Overview

Othman Al-Sawaf, MD, from the University of Cologne,…
Dec 29, 2020| Posted in: Hematologic Disorders, Treatment

Treatment Options for Polycythemia Vera

Andrew Kuykendall, MD, Assistant Member at Moffitt Cancer…
Dec 28, 2020| Posted in: Cancers, Hematologic Disorders

Brentuximab Vedotin Continues to Provide Improvement for Peripheral T-cell Lymphoma Patients

Thanos Zomas, MD, from Takeda Oncology, discusses 5-year…

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

TTR Amyloidosis CME Program

Morie A Gertz, MD, MACP provides an overview of TTR Amyloidosis – including how to shorten individuals’ diagnostic journey and the time till they access treatment which might improve their quality of life or even prevent disease progression – through these brief courses that are certified for CME credit.

Rare Disease Clinical Trials CME Program

Learn about clinical trials and rare diseases through these brief courses that are certified for CME and CNE credit.
  • Heather Lau, MD, MS, NYU School of Medicine, New York, NY
  • Morie A Gertz, MD, Mayo Clinic, Rochester, MN
  • Timothy Craig, DO, Penn State University, Hershey, PA
  • Eric T. Wong, MD, Harvard Medical School, Boston, MA

Hematologic Disorders

Topics